Connect Biopharma Appoints Barry Quart As CEO And Director, David Szekeres As President, And Kleanthis Xanthopoulos As New Chair
Portfolio Pulse from Benzinga Newsdesk
Connect Biopharma has appointed Barry Quart as CEO and Director, David Szekeres as President, and Kleanthis Xanthopoulos as the new Chair. The previous CEO, Zheng Wei, and Chair, Wubin (Bill) Pan, will remain on the Board and serve as advisors during the transition.
June 12, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Connect Biopharma has announced significant leadership changes with Barry Quart appointed as CEO, David Szekeres as President, and Kleanthis Xanthopoulos as Chair. The previous CEO and Chair will remain on the Board as advisors.
Leadership changes often signal strategic shifts and can impact investor sentiment. The appointment of experienced leaders like Barry Quart and David Szekeres is likely to be viewed positively, suggesting potential for new growth and stability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100